Dynamic risk assessment in patients with differentiated thyroid cancer

被引:0
|
作者
Abelleira, Erika [1 ]
Jerkovich, Fernando [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose San Martin UBA, Div Endocrinol, Cordoba 2351,5th floor, RA-1120 Cordoba, Buenos Aires, Argentina
来源
关键词
Dynamic risk assessment; Risk of recurrence; Differentiated thyroid cancer; Thyroid cancer; CLINICALLY SIGNIFICANT DISEASE; RADIOIODINE REMNANT ABLATION; FALSE-POSITIVE ABNORMALITIES; RADIOACTIVE IODINE THERAPY; SERIAL NECK ULTRASOUND; QUALITY-OF-LIFE; ACTIVE SURVEILLANCE; PAPILLARY MICROCARCINOMA; STRATIFICATION SYSTEM; MANAGEMENT GUIDELINES;
D O I
10.1007/s11154-023-09857-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current approach for patients with differentiated thyroid carcinoma should be individualized according to the risk of recurrence, and this stratification could be used to identify the risk of persistent/recurrent disease in three scenarios: preoperatively, immediately postoperatively, and during long-term follow-up. The initial risk of recurrence will tailor the management of the patient in the preoperative and immediate postoperative settings, while the dynamic risk, which considers the responses to treatment, could guide the decision-making process for remnant ablation and long-term management.This review provides a summary of the existing information regarding the dynamic risk of recurrence and recommended management for patients with differentiated thyroid cancer. The application of this approach is essential to avoid unnecessary treatments for most patients who will have a favorable prognosis. On the other hand, it allows specific therapeutic interventions for those patients at high risk of recurrence. In the future, analysis of tumor biology and prospective studies will surely improve the accuracy of recurrence risk prediction.
引用
收藏
页码:79 / 93
页数:15
相关论文
共 50 条
  • [41] Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer
    Mukhtar, Noha
    Aljamei, Hadeel
    Aljomaiah, Abeer
    Moria, Yosra
    Alzahrani, Ali S.
    EUROPEAN THYROID JOURNAL, 2021, 10 (03) : 198 - 207
  • [42] Dynamic risk allows us to adequately select patients with differentiated thyroid cancer who do not require radioiodine treatment
    Abelleira, Erika
    Angela Penaloza, Mirna
    Jerkovich, Fernando
    Bueno, Fernanda
    Pitoia, Fabian
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (03): : 315 - 321
  • [43] Effectiveness of lowradioiodine administered activity in patients with low risk differentiated thyroid cancer
    Yeddes, I., Jr.
    Ben Ghachem, T.
    Meddeb, I.
    Limam, K.
    Somaii, M.
    Slim, I.
    Ben Slimene, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S373 - S373
  • [44] Is denying RAI ablation in the low risk differentiated thyroid cancer patients justified?
    Agrawal, K.
    Kashyap, R.
    Bhattacharya, A.
    Mittal, B. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S223 - S224
  • [45] Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer
    Campenni, Alfredo
    Ruggeri, Rosaria Maddalena
    Siracusa, Massimiliano
    Giacoppo, Giulia
    La Torre, Flavia
    Saccomanno, Angiola
    Alibrandi, Angela
    Dionigi, Gianlorenzo
    Tuccari, Giovanni
    Baldari, Sergio
    Giovanella, Luca
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (03) : 397 - 404
  • [46] Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer
    Klain, Michele
    Zampella, Emilia
    Manganelli, Mariarosaria
    Gaudieri, Valeria
    Nappi, Carmela
    D'Antonio, Adriana
    Piscopo, Leandra
    Volpe, Fabio
    Pace, Leonardo
    Schlumberger, Martin
    Cuocolo, Alberto
    ENDOCRINE, 2021, 71 (02) : 378 - 384
  • [47] Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer
    Manganelli, M.
    Klain, M.
    Zampella, E.
    Volpe, F.
    Piscopo, L.
    De Risi, M.
    De Risi, M.
    Gaudieri, V.
    Nappi, C.
    D' Antonio, A.
    Limone, S.
    Pace, L.
    Cuocolo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S179 - S180
  • [48] Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer
    Michele Klain
    Emilia Zampella
    Mariarosaria Manganelli
    Valeria Gaudieri
    Carmela Nappi
    Adriana D’Antonio
    Leandra Piscopo
    Fabio Volpe
    Leonardo Pace
    Martin Schlumberger
    Alberto Cuocolo
    Endocrine, 2021, 71 : 378 - 384
  • [49] Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe
    Michel Henry-Amar
    Jean-Jacques Michels
    Jean-Pierre Rame
    Pascaline Berthet
    Emmanuel Babin
    Philippe Icard
    Guy Samama
    Françoise Galateau-Sallé
    Jacques Mahoudeau
    Stéphane Bardet
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 685 - 691
  • [50] Risk of second primary cancer following differentiated thyroid cancer
    Berthe, E
    Henry-Amar, M
    Michels, JJ
    Rame, JP
    Berthet, P
    Babin, E
    Icard, P
    Samama, G
    Galateau-Sallé, F
    Mahoudeau, J
    Bardet, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (05) : 685 - 691